DPYD and cancer: Single nucleotide variants in DPYD have been linked to increased risk of severe toxicity following fluorouracil treatment in European (Saif, 2013) and Asian (Zhang et al., 2012) cancer patient cohorts, and a variant specific to African Americans (compared to European Americans) was found to reduce DPD activity (Offer et al., 2013).